Inference of social cognition in schizophrenia patients with neurocognitive domains and neurocognitive tests using automated machine learning，Asian Journal of Psychiatry, vol.91 pp.103866-1-103866- SCI 2024 Lin E、Lin CH、藍先元(Lane, Hsien Yuan)*
Discrepancy of social cognition between bipolar disorders and major depressive disorders，Brain and Behavior, vol.14 pp.e3365-1-e3365-11 SCI 2024 Chang YH(Chang YH)*、Yu CL、Huang CC、Wang TY、Dziobek I、藍先元(Lane, Hsien Yuan)
Elucidating the Mechanisms of Sodium Benzoate in Alzheimer's Disease: Insights from Quantitative Proteomics Analysis of Serum Samples，INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, vol.26 pp.856-866 SCI 2023 Lin CH、Liao HY、藍先元(Lane, Hsien Yuan)*、Chen CJ
Adjunctive transcranial direct current stimulation (tDCS) plus sodium benzoate for the treatment of early-phase Alzheimer's disease: A randomized, double-blind, placebo-controlled tria.，PSYCHIATRY RESEARCH, vol.328 pp.115461-1-115461- SSCI 2023 藍先元(Lane, Hsien Yuan)、Wang SH、Lin CH(Lin CH)*
Differential impacts of endogenous antioxidants on clinical symptoms and cognitive function in acute and chronic schizophrenia patients，INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, vol.26 no.8 pp.576-583 SCI 2023 Lin CH、Li TM、Huang YJ、Chen SJ、藍先元(Lane, Hsien Yuan)*
Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies，SCHIZOPHRENIA RESEARCH, vol.22 pp.S0920-S9964(23) SSCI 2023 Ruan CJ(Ruan CJ)*、Olmos I、Ricciardi C、Schoretsanitis G、Vincent PD、An?l Ya?c?o?lu AE、Eap CB、Baptista T、Clark SR、Fernandez-Egea E、藍先元(Lane, Hsien Yuan)
Determination of D-serine and D-alanine Tissue Levels in the Prefrontal Cortex and Hippocampus of Rats After a Single Dose of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, with Potential Antipsychotic and Antidepressant Properties，NEUROCHEMICAL RESEARCH, vol.48 pp.2066-2076 SCI 2023 Huang CC(Huang CC)*、Wei IH、Yang HT、藍先元(Lane, Hsien Yuan)
Differential Relationships of NMDAR Hypofunction and Oxidative Stress With Cognitive Decline，PSYCHIATRY RESEARCH, vol.326 pp.115288-1-15288-9 SSCI 2023 藍先元(Lane, Hsien Yuan)、Wang SH、Lin CH(Lin CH)*
A brief history of clozapine use in Taiwan，SCHIZOPHRENIA RESEARCH, vol.29 pp.S0920-S9964(23) SSCI 2023 Lin SK、藍先元(Lane, Hsien Yuan)*
Sodium benzoate: A novel multi-target pharmaceutical approach to rescue clozapine-resistant schizophrenia，SCHIZOPHRENIA RESEARCH, vol.23 pp.S0920-S9964(23) SSCI 2023 Lin CH、藍先元(Lane, Hsien Yuan)*
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition，SCHIZOPHRENIA RESEARCH, vol.31 pp.S0920-9964(23) SSCI 2023 Schoretsanitis G(Schoretsanitis G)*、An?l Ya?c?o?lu AE、Ruan CJ, Eap CB、Molden E、Baptista T、Clark SR、Fernandez-Egea E、Kim SH、藍先元(Lane, Hsien Yuan)、Leung J
The associations between cognitive functions and TSNAX genetic variations in patients with schizophrenia，PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, vol.225 pp.173554-1-173554- SCI 2023 Huang KY、Huang YJ、Chen SJ、Lin CH、藍先元(Lane, Hsien Yuan)*
The identification of a potential plasma metabolite marker for Alzheimer's disease by LC-MS untargeted metabolomics，JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, vol.1222 pp.123686-1-123686- SCI 2023 Lin CH、Lin YN、藍先元(Lane, Hsien Yuan)*、Chen CJ
Ketamine, benzoate, and sarcosine for treating depression，NEUROPHARMACOLOGY, vol.223 pp.109351-1-109351- SCI 2023 Cheng YJ、Lin CH、藍先元(Lane, Hsien Yuan)*
Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease，PSYCHIATRY AND CLINICAL NEUROSCIENCES, vol.77 no.2 pp.102-109 SCI 2023 藍先元(Lane, Hsien Yuan)、Wang SH、Lin CH(Lin CH)*
Diagnosing Alzheimer's disease specifically and sensitively with pLG72 and cystine/glutamate antiporter SLC7A11 as blood biomarkers，INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, vol.26 no.1 pp.1-8 SCI 2023 藍先元(Lane, Hsien Yuan)、Lin CH(Lin CH)*
Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research，CNS DRUGS, vol.36 no.11 pp.1143-1153 SCI 2022 Kuo CY、Lin CH、藍先元(Lane, Hsien Yuan)*
Blood D-Amino Acid Oxidase Levels Increased With Cognitive Decline Among People With Mild Cognitive Impairment: A Two-Year Prospective Study，INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, vol.25 no.8 pp.660-665 SCI 2022 Lin CH、藍先元(Lane, Hsien Yuan)*
Effects of sodium benzoate, a D-amino acid oxidase inhibitor, on perceived stress and cognitive function among patients with late-life depression: A randomized, double-blind, sertraline- and placebo-controlled trial，INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, vol.25 no.7 pp.545-555 SCI 2022 Lin CH、Wang SH、藍先元(Lane, Hsien Yuan)*
Editorial: Modulation of NMDA Receptors: From Bench Side to Clinical Applications in Psychiatry，Frontiers in Psychiatry, vol.13 pp.896327-1-896327- SCI 2022 Petronijevi? N(Petronijevi? N)*、藍先元(Lane, Hsien Yuan)、Radonji? NV
A bagging ensemble machine learning framework to predict overall cognitive function of schizophrenia patients with cognitive domains and tests，Asian Journal of Psychiatry, vol.69 pp.103008-1-103008- SCI 2022 Lin E、Lin CH、藍先元(Lane, Hsien Yuan)*
Distinctively lower DISC1 mRNA levels in patients with schizophrenia, especially in those with higher positive, negative, and depressive symptoms，PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, vol.13 pp.173335-1-173335- SCI 2022 Chen YM、Lin CH、藍先元(Lane, Hsien Yuan)*
De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update，Journal of Chemical Information and Modeling, vol.62 pp.761-774 SCI 2022 Lin E、Lin CH、藍先元(Lane, Hsien Yuan)*
Suicide Ideation among Outpatients with Alcohol Use Disorder，BEHAVIOURAL NEUROLOGY, vol.2022 pp.4138629-1-413862 SCI 2022 Hsu WY、Chang TG、Chang CC、Chiu NY、Lin CH、藍先元(Lane, Hsien Yuan)*
Logistic ridge regression to predict bipolar disorder using mRNA expression levels in the N-methyl-D-aspartate receptor genes，JOURNAL OF AFFECTIVE DISORDERS, vol.297 pp.309-311 SSCI 2022 Lin E、Lin CH、藍先元(Lane, Hsien Yuan)*
An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels，PHARMACOPSYCHIATRY, vol.15 pp.1-37 SCI 2021 de Leon J(de Leon J)*、Schoretsanitis G、Smith RL、Molden E、Solismaa A、Seppala N、Kope?ek M、?vancer P、Olmos I、Ricciardi C
Efficiency of the on-line health promotion program in the individuals with at-risk mental state under the COVID-19 pandemic，International Journal of Environmental Research and Public Health, vol.18 pp.11875-1-11875-12 SSCI 2021 Tsai CL、u CH、Chen JC、藍先元(Lane, Hsien Yuan)*、Ma WF
Plasma Glutathione Levels Decreased with Cognitive Decline among People with Mild Cognitive Impairment (MCI): A Two-Year Prospective Study，Antioxidants, vol.10 pp.1839-1-1839-9 SCI 2021 Lin CH、藍先元(Lane, Hsien Yuan)*
From Menopause to Neurodegeneration-Molecular Basis and Potential Therapy，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol.22 pp.8654-1-8654-28 SCI 2021 Cheng YJ、Lin CH、藍先元(Lane, Hsien Yuan)*
Novel Biomarkers of Alzheimer's Disease: Based Upon N-methyl-D-aspartate Receptor Hypoactivation and Oxidative Stress，Clinical Psychopharmacology and Neuroscience, vol.19 no.3 pp.423-433 SCI 2021 Chiang TI、Yu YH、Lin CH、藍先元(Lane, Hsien Yuan)*
Deep Learning with Neuroimaging and Genomics in Alzheimer’s Disease，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol.22 pp.7911-1-7911-20 SCI 2021 Lin E、Lin CH、藍先元(Lane, Hsien Yuan)*
Characterization of Potential Protein Biomarkers for Major Depressive Disorder Using Matrix-Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectrometry，MOLECULES, vol.26 pp.4457-1-4457-15 SCI 2021 Lin CH、Su H、Hung CC、藍先元(Lane, Hsien Yuan)*、Shiea J
Novel Therapeutic Approaches for Alzheimer's Disease: An Updated，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol.22 pp.8208-1-8208-29 SCI 2021 Yu TW、藍先元(Lane, Hsien Yuan)*、Lin CH
Molecular Basis of Late-Life Depression，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol.22 pp.7421-1-7421-14 SCI 2021 Kuo CY、Lin CH、藍先元(Lane, Hsien Yuan)*
Explore the Effects of Pharmacological, Psychosocial, and Alternative /Complementary Interventions in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder，INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY pp.pyab034-1-pyab03 SCI 2021 Yang KH、藍先元(Lane, Hsien Yuan)、Chang YC、Tzang RF(Tzang RF)*
In Reply: Trough Melatonin Levels Have No Physiological or Clinical Relevance，Clinical Psychopharmacology and Neuroscience, vol.19 no.2 pp.393- SCI 2021 Lin CH、藍先元(Lane, Hsien Yuan)*
Prediction of functional outcomes of schizophrenia with genetic biomarkers using a bagging ensemble machine learning method with feature selection，Scientific Reports, vol.11 pp.10179-1-10179-8 SCI 2021 Lin E、Lin CH、藍先元(Lane, Hsien Yuan)*
Risk Assessment for Heroin Use and Craving Score Using Polygenic Risk Score，Journal of Personalized Medicine, vol.11 pp.259-1-259-7 SCI 2021 Huang CL、Chen PH、藍先元(Lane, Hsien Yuan)、Ho IK、Ching CH(Ching CH)*
Deep neural network to differentiate brain activity between Patients with First-Episode Schizophrenia and Healthy Individuals: a multi-channel near infrared spectroscopy study，Frontiers in Psychiatry, vol.12 pp.655292-1-655292- SSCI 2021 Chou PH(Chou PH)*、Yao YH、Zeng RX、Liou YL、Liu YL、藍先元(Lane, Hsien Yuan)、Yang AC、Wang SC
Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial.，JAMA Network Open, vol.4 pp.e216156-1-e21615 SCI 2021 Lin CH、Chen PK、Wang SH、藍先元(Lane, Hsien Yuan)*
Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions，Scientific Reports, vol.11 pp.6922-1-6922-9 SCI 2021 Lin E、Lin CH、藍先元(Lane, Hsien Yuan)*
Machine learning and novel biomarkers for the diagnosis of Alzheimer’s disease，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol.22 pp.2761-1-2761-12 SCI 2021 Chang CH、Lin CH,、藍先元(Lane, Hsien Yuan)*
Trough Melatonin Levels Differ between Early and Late Phases of Alzheimer Disease，Clinical Psychopharmacology and Neuroscience, vol.19 no.1 pp.135-144 SCI 2021 Lin CH、Chiu CC、藍先元(Lane, Hsien Yuan)*
Plasma D-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches，JOURNAL OF PSYCHOPHARMACOLOGY, vol.15 pp.1-8 SCI 2021 Chang CH、Lin CH、Liu CY、Huang CS、Chen SJ、Lin WC、Yang HT、藍先元(Lane, Hsien Yuan)*
Effects of the Health-Awareness-Strengthening Lifestyle Program in a Randomized Trial of Young Adults with an At-Risk Mental State，International Journal of Environmental Research and Public Health, vol.18 pp.1959-1-1959-13 SSCI 2021 Tsai CL、Lin YW、Hsu HC、Lou ML、藍先元(Lane, Hsien Yuan)、Tu CH、Ma WF(Ma WF)*
Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol.22 no.4 pp.2146-1-2146-26 SCI 2021 Goh KK、Chen CH(Chen CH)*、藍先元(Lane, Hsien Yuan)
Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer's Disease，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol.22 no.5 pp.2283-1-2283-15 SCI 2021 Cheng YJ、Lin CH、藍先元(Lane, Hsien Yuan)*
Brain activity of benzoate, a D-amino acid oxidase inhibitor, in patients with mild cognitive impairment in a randomized, double-blind, placebo controlled clinical trial，INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY pp.1-8 SCI 2021 藍先元(Lane, Hsien Yuan)、Tu CH、Lin WC、Lin CH(Lin CH)*
D2 dopamine receptor gene (DRD2) Taq1A (rs1800497) affects bone density，Scientific Reports, vol.10 pp.13236-1-13236-9 SCI 2020 Chiang TI、藍先元(Lane, Hsien Yuan)*、Lin CH
Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design，MOLECULES, vol.25 pp.E3250-1-E3250-25 SCI 2020 Lin E、Lin CH、藍先元(Lane, Hsien Yuan)*
Benzoate treatment for adolescent anti-NMDAR encephalitis，SCHIZOPHRENIA RESEARCH, vol.25 pp.s0920-s9964 SSCI 2020 Tzang RF、Chang YC、藍先元(Lane, Hsien Yuan)*
An ensemble approach to predict schizophrenia using protein data in the N-methyl-D-aspartate receptor (NMDAR) and tryptophan catabolic pathways，Frontiers in Bioengineering and Biotechnology, vol.8 pp.569-1-569-9 SCI 2020 Lin E、Lin CH(Lin CH)*、Hung CC、藍先元(Lane, Hsien Yuan)
Effect of antidepressants for cessation therapy in betel-quid use disorder: A randomized, double-blind, placebo-controlled trial，Epidemiology and Psychiatric Sciences, vol.29 pp.e125-1-e125-10 SSCI 2020 Hung CC、Lee CH、Ko AM、藍先元(Lane, Hsien Yuan)、Lee CP、Ko YC(Ko YC)*
d-glutamate and Gut Microbiota in Alzheimer’s Disease，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol.21 pp.2676-1-2676-17 SCI 2020 Chang CH、Lin CH、藍先元(Lane, Hsien Yuan)*
Efficacy and cognitive effect of sarcosine (N-methylglycine) in patients with schizophrenia: A systematic review and meta-analysis of double-blind randomised controlled trials，JOURNAL OF PSYCHOPHARMACOLOGY, vol.2 pp.1-11 SCI 2020 Chang CH、Lin CH、Liu CY、Chen SJ、藍先元(Lane, Hsien Yuan)*
Genetic effects of DISC1 and G72 (DAOA) on visual learning of patients with schizophrenia，Neuropsychiatric Disease and Treatment, vol.16 pp.771-780 SCI 2020 Chang PJ、Huang KH、Lin CH、藍先元(Lane, Hsien Yuan)*
Impairments in face discrimination and emotion recognition are related to aging and cognitive dysfunctions in Parkinson's disease with dementia，Scientific Reports, vol.10 pp.4367-1-4367-8 SCI 2020 Ho MW、Chien SH(Chien SH)*、 Lu MK、Chen JC、Aoh Y、Chen CM、藍先元(Lane, Hsien Yuan)、Tsai CH
Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)，Neuropsychiatric Disease and Treatment, vol.16 pp.509-518 SCI 2020 Lin CH、Yang HT、Chen PK、Wang SH、藍先元(Lane, Hsien Yuan)*
Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches，INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, vol.21 pp.969-1-969-15 SCI 2020 Lin E、Lin CH、藍先元(Lane, Hsien Yuan)*
Antidepressant-induced reduction in betel-quid use in patients with depression - a pioneer clinical study，MEDICINE, vol.99 no.1 pp.e18672-1-e18672- SCI 2020 Hung CC、Lee CH、Chung CM、Nithiyanantham S、藍先元(Lane, Hsien Yuan)、Ko YC(Ko YC)*
Srvey of NMDA Receptor-related Biomarkers for Depression，CURRENT PHARMACEUTICAL DESIGN, vol.26 pp.1-10 SCI 2020 Chen YM、Lin CH、藍先元(Lane, Hsien Yuan)*
Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders，Frontiers in Psychiatry, vol.10 pp.904-1-904-3 SSCI 2019 Chieh-Hsin Lin、Kenji Hashimoto、藍先元(Lane, Hsien Yuan)*
Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia，Scientific Reports, vol.9 pp.18840-1-18840-8 SCI 2019 Chieh-Hsin Lin、Sheng Yang、Yu-Jhen Huang、藍先元(Lane, Hsien Yuan)*
The Role of N-methyl-D-aspartate Receptor on Late-Life Depression，International Journal of Gerontology, vol.13 no.4 pp.268-272 SCI 2019 Men-Ting Hsieh、藍先元(Lane, Hsien Yuan)、Chieh-Hsin Lin(Chieh-Hsin Lin)*
Novel Treatment for the hardest-to-treat Schizophrenia: Dual Activation of NMDA Receptor and Antioxidant，CURRENT DRUG TARGETS SCI 2019 Chieh-Hsin Lin、Yu-Ming Chen、藍先元(Lane, Hsien Yuan)*
Paliperidone is associated with reduced risk of severe hepatic outcome in patients with schizophrenia and viral hepatitis: A nationwide population-based cohort study，PSYCHIATRY RESEARCH, vol.281 pp.112597-1-112597- SSCI 2019 Chang CH、藍先元(Lane, Hsien Yuan)*、Liu CY、Chen SJ、Lin CH
pLG72 levels increase in early phase of Alzheimer's disease but decrease in late phase.，Scientific Reports, vol.99 pp.13221-1-13221-9 SCI 2019 Lin CH、Chiu CC、Huang CH、Yang HT、藍先元(Lane, Hsien Yuan)*
C-reactive protein is associated with severity of thought and language dysfunction in patients with schizophrenia，Neuropsychiatric Disease and Treatment, vol.15 pp.2621-2627 SCI 2019 Chang CH、藍先元(Lane, Hsien Yuan)*、Liu CY、Cheng PC、Chen SJ、 Lin CH
Sodium benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD): a randomized, double-blind, placebo-controlled, 6-week trial.，JOURNAL OF PSYCHOPHARMACOLOGY, vol.33 no.8 pp.1030-1033 SCI 2019 Lin CH、Chen PK、Wang SH、藍先元(Lane, Hsien Yuan)*
D-glutamate, D-serine, and D-alanine differ in their roles in cognitive decline in patients with Alzheimer's disease or mild cognitive impairment.，PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, vol.185 pp.172760-1-172760- SCI 2019 Lin CH、Yang HT、藍先元(Lane, Hsien Yuan)*
Recovery of cognitive functioning following abstinence from ketamine.，ADDICTIVE BEHAVIORS, vol.99 pp.106081-1-106081- SSCI 2019 Tang WK(Tang WK)*、Lau CG、Ungvari GS、Lin SK、藍先元(Lane, Hsien Yuan)
Autism associated with anti-NMDAR encephalitis: glutamate-related therapy.，Frontiers in Psychiatry, vol.10 pp.440-1-440-6 SSCI 2019 Tzang RF、Chang CH、Chang YC、藍先元(Lane, Hsien Yuan)*
The role of N-methyl-D-aspartate receptor neurotransmission and precision medicine in behavioral and psychological symptoms of dementia.，Frontiers in Pharmacology, vol.10 pp.540-1-540-9 SCI 2019 Lin CH、藍先元(Lane, Hsien Yuan)*
Effect of N-methyl-D-aspartate-receptor-enhancing agents on cognition in patients with schizophrenia: a systematic review and meta-analysis of double-blind randomised controlled trials，JOURNAL OF PSYCHOPHARMACOLOGY, vol.33 no.4 pp.436-448 SCI 2019 Chang CH、藍先元(Lane, Hsien Yuan)、Tseng PT、Chen SC、Liu CY、Lin CH(Lin CH)*
The association between cigarette smoking and obstructive sleep apnea.，Tobacco Induced Diseases, vol.17 pp.27-1-27-7 SCI 2019 Hsu WY、Chiu CC、Chang CC、Chang TG、藍先元(Lane, Hsien Yuan)*
Long-term use of clozapine is protective for bone density in patients with schizophrenia.，Scientific Reports, vol.9 pp.3895-1-3895-7 SCI 2019 Lin CH、Lin CY、Wang HS、藍先元(Lane, Hsien Yuan)*
Early identification and intervention of schizophrenia: insight from hypotheses of glutamate dysfunction and oxidative stress.，Frontiers in Psychiatry, vol.10 pp.93-1-93-9 SSCI 2019 Lin CH、藍先元(Lane, Hsien Yuan)*
Altered mRNA expressions for N-methyl-D-aspartate receptor-related genes in WBC of patients with major depressive disorder，JOURNAL OF AFFECTIVE DISORDERS, vol.245 pp.1119-1125 SSCI 2018 Lin CH、Huang MW、Lin CH、Huang CH、藍先元(Lane, Hsien Yuan)*
Combination of G72 genetic variation and G72 protein level to detect schizophrenia: machine learning approaches.，Frontiers in Psychiatry, vol.9 pp.566-1-566--7 SSCI 2018 Lin E、Lin CH、Lai YL、Huang CH、Huang YJ、藍先元(Lane, Hsien Yuan)*
Brain Stimulation in Alzheimer’s Disease，Frontiers in Psychiatry, vol.9 pp.1-13 SSCI 2018 Chun-Hung Chang、藍先元(Lane, Hsien Yuan)、Chieh-Hsin Lin(Chieh-Hsin Lin)*
New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity，NEURAL PLASTICITY SCI 2017 Yu-Jhen Huang、藍先元(Lane, Hsien Yuan)、Chieh-Hsin Lin(Chieh-Hsin Lin)*